These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28403994)

  • 41. European guidelines on perioperative venous thromboembolism prophylaxis: Patients with preexisting coagulation disorders and after severe perioperative bleeding.
    Ahmed A; Kozek-Langenecker S; Mullier F; Pavord S; Hermans C;
    Eur J Anaesthesiol; 2018 Feb; 35(2):96-107. PubMed ID: 29112549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review.
    Adam SS; McDuffie JR; Ortel TL; Williams JW
    Ann Intern Med; 2012 Dec; 157(11):796-807. PubMed ID: 22928173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.
    Chai-Adisaksopha C; Hillis C; Isayama T; Lim W; Iorio A; Crowther M
    J Thromb Haemost; 2015 Nov; 13(11):2012-20. PubMed ID: 26356595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis.
    Romanelli RJ; Nolting L; Dolginsky M; Kym E; Orrico KB
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):126-34. PubMed ID: 26812933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis.
    Nagata N; Yasunaga H; Matsui H; Fushimi K; Watanabe K; Akiyama J; Uemura N; Niikura R
    Gut; 2018 Oct; 67(10):1805-1812. PubMed ID: 28874418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data.
    Kohsaka S; Murata T; Izumi N; Katada J; Wang F; Terayama Y
    Curr Med Res Opin; 2017 Nov; 33(11):1955-1963. PubMed ID: 28857611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants.
    Pollack CV; Peacock WF; Bernstein RA; Clark CL; Douketis J; Fermann GJ; Fiore GJ; Frost A; Jahromi B; Johnson C; Merli G; Silber S; Villines TC; Fanikos J;
    Am J Emerg Med; 2020 Jun; 38(6):1163-1170. PubMed ID: 32014375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.
    Sherwood MW; Nessel CC; Hellkamp AS; Mahaffey KW; Piccini JP; Suh EY; Becker RC; Singer DE; Halperin JL; Hankey GJ; Berkowitz SD; Fox KAA; Patel MR
    J Am Coll Cardiol; 2015 Dec; 66(21):2271-2281. PubMed ID: 26610874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Khuu W; Frymire E; Johnson AP;
    Chest; 2017 Jul; 152(1):81-91. PubMed ID: 28219635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation.
    Baker WL; Phung OJ
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):711-9. PubMed ID: 22912382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Which oral anticoagulant for atrial fibrillation.
    Med Lett Drugs Ther; 2016 Apr; 58(1492):45-6. PubMed ID: 27049507
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
    Morishima Y; Honda Y; Kamisato C; Shibano T
    Thromb Res; 2013 Aug; 132(2):234-9. PubMed ID: 23768448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Taking Warfarin with Heparin Replacement and Direct Oral Anticoagulant Is a Risk Factor for Bleeding after Endoscopic Submucosal Dissection for Early Gastric Cancer.
    Sanomura Y; Oka S; Tanaka S; Yorita N; Kuroki K; Kurihara M; Mizumoto T; Yoshifuku Y; Chayama K
    Digestion; 2018; 97(3):240-249. PubMed ID: 29421806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation.
    Hernandez I; Zhang Y; Saba S
    Am J Cardiol; 2017 Nov; 120(10):1813-1819. PubMed ID: 28864318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.
    Melkonian M; Jarzebowski W; Pautas E; Siguret V; Belmin J; Lafuente-Lafuente C
    J Thromb Haemost; 2017 Jul; 15(7):1500-1510. PubMed ID: 28393461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
    Schulman S; Kakkar AK; Goldhaber SZ; Schellong S; Eriksson H; Mismetti P; Christiansen AV; Friedman J; Le Maulf F; Peter N; Kearon C;
    Circulation; 2014 Feb; 129(7):764-72. PubMed ID: 24344086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An update on hip fracture risk associated with anticoagulant therapy: warfarin versus direct oral anticoagulants.
    Sugiyama T
    Expert Opin Drug Saf; 2020 Oct; 19(10):1219-1220. PubMed ID: 32795203
    [No Abstract]   [Full Text] [Related]  

  • 59. Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis.
    Chai-Adisaksopha C; Hillis C; Monreal M; Witt DM; Crowther M
    Thromb Haemost; 2015 Oct; 114(4):819-25. PubMed ID: 26018236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.
    Abraham NS; Noseworthy PA; Yao X; Sangaralingham LR; Shah ND
    Gastroenterology; 2017 Apr; 152(5):1014-1022.e1. PubMed ID: 28043907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.